PMID- 22296829 OWN - NLM STAT- MEDLINE DCOM- 20120815 LR - 20211021 IS - 1878-5905 (Electronic) IS - 0142-9612 (Print) IS - 0142-9612 (Linking) VI - 33 IP - 11 DP - 2012 Apr TI - Antitumor immunologically modified carbon nanotubes for photothermal therapy. PG - 3235-42 LID - 10.1016/j.biomaterials.2011.12.029 [doi] AB - An immunologically modified nanotube system was developed using an immunoadjuvant, glycated chitosan (GC), as surfactant of single-walled carbon nanotube (SWNTs). This SWNT-GC system not only retained both optical properties of SWNTs and immunological functions of GC, but also could enter cells due to the carrier properties of SWNTs. Cellular SWNTs induced thermal destruction of tumor cells when irradiated by a near-infrared laser and, at the same time, cellular GC could serve both as damage associated molecular pattern molecules (DAMPs) and pathogen associated molecular pattern molecules (PAMPs) to enhance the tumor immunogenicity and enhance the uptake and presentation of tumor antigens, leading to special antitumor response. Using this system and a 980 nm laser, we treated tumors, both in vitro and in vivo, and investigated the induced thermal and immunological effects. Laser + SWNT-GC afford a remarkable efficacy in suppressing tumor growth in animal cancer models, in many cases resulting in complete tumor regression and long-term survival. Mice successfully treated by Laser + SWNT-GC could establish resistance to tumor rechallenge. This system forms a multifunctional temporal-spatial continuum, which can synergize photothermal and immunological effects. The Laser + SWNT-GC could represent a promising treatment modality to induce systemic antitumor response through a local intervention, while minimizing the adverse side effects. CI - Copyright (c) 2011 Elsevier Ltd. All rights reserved. FAU - Zhou, Feifan AU - Zhou F AD - MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou 510631, China. FAU - Wu, Shengnan AU - Wu S FAU - Song, Sheng AU - Song S FAU - Chen, Wei R AU - Chen WR FAU - Resasco, Daniel E AU - Resasco DE FAU - Xing, Da AU - Xing D LA - eng GR - P20 RR016478/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120131 PL - Netherlands TA - Biomaterials JT - Biomaterials JID - 8100316 RN - 0 (Antineoplastic Agents) RN - 0 (Nanotubes, Carbon) RN - 9012-76-4 (Chitosan) SB - IM MH - Animals MH - Antineoplastic Agents/*administration & dosage/chemistry/immunology MH - Cell Line, Tumor MH - Chitosan/*chemistry/immunology/*therapeutic use MH - Female MH - Low-Level Light Therapy/*methods MH - Mammary Neoplasms, Animal/*immunology/pathology/*therapy MH - Mice MH - Mice, Inbred BALB C MH - Nanotubes, Carbon/*chemistry MH - Treatment Outcome PMC - PMC5987227 MID - NIHMS969240 EDAT- 2012/02/03 06:00 MHDA- 2012/08/16 06:00 PMCR- 2018/06/05 CRDT- 2012/02/03 06:00 PHST- 2011/12/01 00:00 [received] PHST- 2011/12/13 00:00 [accepted] PHST- 2012/02/03 06:00 [entrez] PHST- 2012/02/03 06:00 [pubmed] PHST- 2012/08/16 06:00 [medline] PHST- 2018/06/05 00:00 [pmc-release] AID - S0142-9612(11)01499-2 [pii] AID - 10.1016/j.biomaterials.2011.12.029 [doi] PST - ppublish SO - Biomaterials. 2012 Apr;33(11):3235-42. doi: 10.1016/j.biomaterials.2011.12.029. Epub 2012 Jan 31.